Clinical Trials Directory

Trials / Completed

CompletedNCT03278561

General Risk Factors and Inflammatory Determinants in Older Patients With Asthma

Status
Completed
Phase
Study type
Observational
Enrollment
90 (actual)
Sponsor
Gerdien Tramper · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

A cross-sectional study in asthma patients to determine if a late age of onset asthma (start symptoms \>18 years old), is associated with more persistent airway/systemic inflammation, worse asthma control, more co-morbidity, a different microbiome and poorer quality of life despite the use of optimized asthma therapy.

Detailed description

For ages, asthma has been considered a disease for children and young adults. However, nowadays 30% of all asthma patients is over 50 years old. Asthma in the elderly is generally more severe and approximately 50% of all deaths drom asthma occur in this age group. With rapid aging of the global population, the burden of asthma in the elderly will further increase. Asthma is a heterogeneous disease and the question is whether asthma in the elderly can be considered the same disease as asthma in children and young adults. The pathophysiology and risk factors of asthma in the elderly are still not completely understood. Good characterization of asthma in the elderly requires clinical phenotyping as well as a thorough analysis of the underlying cellular and molecular mechanisms. It is hypothesized that in older asthma patients, a late age of onset (start asthma symptoms \>18 years) is associated with more persistent airway/systemic inflammation, worse asthma control, more co-morbidity and poorer quality of life despite the use of optimized asthma therapy.

Conditions

Interventions

TypeNameDescription
PROCEDURESputum inductionSputum induction according to the ERS protocol
PROCEDUREBlood sampleA blood sample of 100ml will be taken.

Timeline

Start date
2017-05-08
Primary completion
2019-08-31
Completion
2019-12-31
First posted
2017-09-11
Last updated
2020-08-14

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT03278561. Inclusion in this directory is not an endorsement.